Back to today’s briefing

Story perspectives

Eli Lilly Hits $1 Trillion, Fueled by Mounjaro Success

11/24/2025

50 4 Full Breakdown

Summary

Story summary

Eli Lilly and Company (LLY) reached a $1 trillion market capitalization this year as its stock rose 36%.
Strong demand for Mounjaro and Zepbound generated over $10 billion in revenue last quarter.
Analysts have issued Strong Buy ratings with price targets as high as $1,500.
The company is expanding access through a new sales model targeting employers.
Concerns about pricing pressures and competition persist.

History

Historical Context

Eli Lilly and Company, founded in 1876 by Eli Lilly, became a pioneer in the pharmaceutical industry, introducing innovations like gelatin capsules. After facing revenue challenges from Prozac's patent expiration in 2004, the company rebounded, achieving a $1 trillion market cap by 2023, driven by new products like Mounjaro and Zepbound, reflecting its strategic shift in a competitive market.

1 of 2

Story summary

Eli Lilly and Company (LLY) reached a $1 trillion market capitalization this year as its stock rose 36%.
Strong demand for Mounjaro and Zepbound generated over $10 billion in revenue last quarter.
Analysts have issued Strong Buy ratings with price targets as high as $1,500.
The company is expanding access through a new sales model targeting employers.
Concerns about pricing pressures and competition persist.

1 / 2